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Background: Myelinated axons are organized into distinct subcellular and molecular regions. Without proper
organization, electrical nerve conduction is delayed, resulting in detrimental physiological outcomes. One such
region is the paranode where axo-glial septate junctions act as a molecular fence to separate the sodium (Na+)
channel-enriched node from the potassium (K+) channel-enriched juxtaparanode. A significant lack of knowledge
remains as to cytoskeletal proteins which stabilize paranodal domains and underlying cytoskeleton. Whirlin (Whrn)
is a PDZ domain-containing cytoskeletal scaffold whose absence in humans results in Usher Syndromes or variable
deafness-blindness syndromes. Mutant Whirlin (Whrn) mouse model studies have linked such behavioral deficits to
improper localization of critical transmembrane protein complexes in the ear and eye. Until now, no reports exist
about the function of Whrn in myelinated axons.
Results: RT-PCR and immunoblot analyses revealed expression of Whrn mRNA and Whrn full-length protein,
respectively, in several stages of central and peripheral nervous system development. Comparing wild-type mice to
Whrn knockout (Whrn−/−) mice, we observed no significant differences in the expression of standard axonal domain
markers by immunoblot analysis but observed and quantified a novel paranodal compaction phenotype in 4 to
8 week-old Whrn−/− nerves. The paranodal compaction phenotype and associated cytoskeletal disruption was
observed in Whrn−/− mutant sciatic nerves and spinal cord fibers from early (2 week-old) to late (1 year-old) stages
of development. Light and electron microscopic analyses of Whrn knockout mice reveal bead-like swellings in
cerebellar Purkinje axons containing mitochondria and vesicles by both. These data suggest that Whrn plays a role
in proper cytoskeletal organization in myelinated axons.
Conclusions: Domain organization in myelinated axons remains a complex developmental process. Here we
demonstrate that loss of Whrn disrupts proper axonal domain organization. Whrn likely contributes to the
stabilization of paranodal myelin loops and axonal cytoskeleton through yet unconfirmed cytoskeletal proteins.
Paranodal abnormalities are consistently observed throughout development (2 wk-1 yr) and similar between central
and peripheral nervous systems. In conclusion, our observations suggest that Whrn is not required for the
organization of axonal domains, but once organized, Whrn acts as a cytoskeletal linker to ensure proper paranodal
compaction and stabilization of the axonal cytoskeleton in myelinated axons.
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Nervous system function depends on proper molecular
organization between neurons and glial cells. In myelin-
ated neurons, the segregation and enrichment of proteins
in the defined domains, the Node of Ranvier, paranode,
and juxtaparanode, is critical for saltatory action potential
propagation [1-4]. Without proper organization, electrical
nerve conduction is delayed and can result in significant
motor and sensory deficits. The paranodal domain is a
region of direct interaction between the glial myelin
membrane loops and neuronal plasma membrane. Axo-
glial septate junctions (AGSJ) link these glial membrane
loops to the axonal membrane and establish the paranodal
ionic barrier separating sodium (Na+) channel-enriched
node from the potassium (K+) channel-enriched juxta-
paranode [5]. AGSJ’s are composed of three transmem-
brane proteins: Contactin (Cont) [6], Contactin-associated
protein (Caspr) [7], and Neurofascin155 (glial-derived
155 kDa isoform) [8]. Genetic ablation of any of the three
molecules disrupts the paranodal barrier function and
results in degraded action potential propagation [6-11].
While much research has focused on these three pro-
teins, other molecules contribute to domain formation
and stabilization. For example, Caspr2 and TAG-1 are
required for the organization of the juxtaparanodal
domain and localization of potassium (K+) channels
[12]. For long-term stability, Caspr and Caspr2 are
thought to rely on cytoskeletal scaffold proteins to link
their associated complexes with the axonal cytoskeleton.
Loss of Caspr results in significant cytoskeletal disorder
[9], and since its extracellular partner Cont lacks an
intracellular c-terminus, the c-terminus of Caspr is likely
a critical region of interaction between AGSJ’s and the
axonal cytoskeleton. Previous studies using 4.1B mutant
mice revealed that the 4.1B cytoskeletal protein contrib-
utes to paranodal and juxtaparanodal stability [13,14]. A
recent report also highlights 4.1G as an organizer of
internodes in the peripheral nervous system [15]. The
neuron is abundant with cytoskeletal scaffolds however,
and such findings do not exclude the possibility that
other cytoskeletal elements may contribute to paranodal
maintenance and long-term stability.
Whrn is a cytoskeletal scaffold protein that plays an
important role in vision and hearing [16,17]. In humans,
WHIRLIN (WHRN) (DFNB31) mutations have been linked
to Usher syndrome Type II (USH2), an autosomal re-
cessive vision-hearing impairment disorder [18,19]. In
mice, the Whrn coding sequence consists of 12 exons
with two dominant splice variants, a full length and short
(exon 5–12) isoform. Both variants contain a Proline-rich
domain and PDZ-domain(s) which have been shown to
link submembranous cytoskeletal elements to transmem-
brane complexes, as well as to self-oligomerize [20]. In
the eye, Whrn interacts with the transmembrane proteinsUsherin (USH2) and Very Large G protein-coupled
Receptor-1 (VLGR1/GPR98) within the periciliary mem-
brane complex of photoreceptors. Likewise in the inner
ear, Whrn interacts with Usherin and VLGR1/GPR98,
which form the stereociliary ankle-links. Additionally,
Whrn interacts indirectly with 4.1B [21] and 4.1R through
Mpp1/p55 [22], and directly with Myosin XVa [23].
Finally, Whrn is implicated with Esp8 in stereocilia-
length regulation [24]. While the function of Whrn in
the ear and the eye has received significant attention,
very little is known about its function in the central
and/or peripheral nervous system. There are reports of
Whrn protein expression in the cerebrum, cerebellum,
and brainstem in wild-type mice and the protein is ab-
sent in Whrn knockout (Whrn−/−) and whirler (Whrnwi/wi)
mutant mice [25]. In Drosophila, the closest homolog to
Whrn is dyschronic (dysc) [26]. In dysc mutants there is
arrhythmic locomotor behavior but the eclosion circadian
rhythms and clock protein cycling is unaffected [26]. Here
we report that Whrn is involved in proper compaction of
the paranodal region in myelinated axons and for proper
stabilization of the axonal cytoskeleton.
Results and discussion
Whrn is expressed in central and peripheral nervous
system tissues throughout development
Whrn is a cytoskeletal scaffolding protein which functions
to link membrane protein complexes to the cytoskeleton
within hair cell stereocilia of the ear and photoreceptors
in the eye. To begin assessing its function in myelinated
neurons, we obtained Whrn exon 1 knockout mice [17].
As reported previously, the murine Whrn locus consists of
12 exons with two dominant splice variants, a full length
(~4 kb) isoform and a short (~2.5 kb) isoform (Figure 1A).
Both variants contain PDZ-domains (Figure 1A, yellow
box) and a Proline-rich domain (Figure 1A, blue box).
After initial back crossing to C57BL6 mouse strain, we
identified and confirmed the Whrn genotype using PCR
methods. To begin characterizing mRNA expression of
Whrn in the central (CNS) and peripheral nervous systems
(PNS), we examined the relative expression of Whrn by
reverse transcriptase polymerase chain reaction (RT-PCR)
in dorsal root ganglia (DRG), sciatic nerves (SN), and
spinal cord (SC) tissues (Figure 1B) in postnatal 21 day-
old mice. With this subset of tissues we could delineate
the origin of Whrn expression as SC tissue is a combin-
ation of glial and neuronal nuclei, DRG is predominantly
neuronal, and SN is principally glial cytoplasm and nuclei.
Since Whrn has two major isoforms, we designed specific
primers to distinguish the full length isoform (Exons 1–4)
alone and those common to the full length and short
isoforms (Exons 9–10). No expression of Whrn isoforms
was observed inWhrn−/− mice (Figure 1B). Robust expres-
sion of Whrn (Exons 1–4) mRNA was observed in DRG
Figure 1 Whirlin (Whrn) is a PDZ-containing protein expressed throughout the central and peripheral nervous system. A. Schematic
showing the relative organization of the twelve exons which make up the Whrn full-length sequence including untranslated exon regions (white
boxes) and coding sequence (alternating grey boxes). Whrn’s second, short isoform begins with an alternative transcriptional start site (asterisks).
Both variants contain PDZ-domains (yellow boxes) and a Proline-rich domain (blue box). A red rectangle highlights the region used for antibody
creation (RbWhrn349). B. RT-PCR analysis shows absence of any Whrn transcripts in homozygous Whrn exon 1 knockout mice from dorsal root
ganglia (DRG, peripheral neuronal nuclei), sciatic nerves (SN, peripheral glial nuclei), and spinal cords (SC, combination neuronal/glial nuclei).
mRNA transcripts were reverse transcribed and amplified using primers located on Whrn exon 1 and 4 (top panel), Whrn exon 9 and 10 (middle
panel), or actin (bottom panel). C. Relative quantification of Whrn mRNA from Figure 1B expressed as a ratio of Whrn to actin band intensity.
D. Immunoblots of 110 kDa Whrn protein band in wild-type and Whrn mutant DRG, SN, SC, and whole eye using affinity-purified RbWhrn349
antibody. αTubulin served as a loading control. E. Immunoblots of wild-type and Whrn knockout mutant 4, 6, 8, and 16-week-old spinal cord
lysates. The expression profile using various myelinated axonal domain markers includes Caspr, Neurofascin (186 and 155), 4.1B, Caspr2, as well as
CASK. αTubulin served as a loading control. F. Immunofluorescence of teased sciatic nerve fibers from wild-type (upper panel) and Whrn
knockout mice (lower panel) mice. Neurofascin (NFCt, red) and paranodal Caspr (green) reveal paranodal compaction is disrupted in Whrn
knockout fibers. Note NFCt (red) detects both paranodal NF155 and nodal NF186 isoforms.
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SN tissue. Interestingly, weak expression of Whrn (Exons
9–10) mRNA was observed in DRG and SC tissue but
no significant expression was observed in SN tissue.
Actin (Exons 2–4) mRNA expression was used as a
control for total RNA present. Relative expression was
quantified as a ratio of Whrn to Actin mRNA between
three total RT-PCR analyses (Figure 1C). After finding
Whrn mRNA expression in the wild-type CNS and
PNS neuronal tissues, we next sought to determine its
protein expression in P30 Whrn+/+ versus Whrn−/− mice
by immunoblot analysis. In order to pursue these ex-
periments, we generated several antibodies and affinity-
purified one to the non-domain encoding, c-terminal
region (aa699-804) of Whrn (Figure 1A, red bar). Afteraffinity-purification, wild-type (+) and Whrn knockout
(−) lysates derived from DRG, SN, SC, and whole eye
were immunoblotted (Figure 1D, upper blots). Whole
eye lysates were used as a positive control for protein
expression based on previous reports [17]. A 110 kDa
Whrn band representing the full length protein was
present in DRG, SC, and whole eye lysates. No 110 kDa
Whrn band was observed in Whrn−/− lysates or in
wild-type SN lysate. Each tissue type showed similar
total protein levels between genotypes based on total
Tubulin on immunoblots (Figure 1D, lower blots). Having
confirmed Whrn−/− tissues were deficient in Whrn mRNA
and protein, we next sought to determine if loss of Whrn
resulted in altered protein expression of known nodal,
paranodal, and juxtaparanodal proteins. We prepared spinal
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and Whrn knockout (−/−) mice and immunoblotted for
Whrn (110 kDa) (Figure 1E). Whrn protein expression
levels were similar from 4 to 16 weeks in wild-type mice
while no expression was observed in the Whrn−/− at any
time point. Next, we immunoblotted for the paranodal
protein Caspr (190 kDa) and found similar expression
levels between 4–16 week-old in both Whrn+/+ and
Whrn−/− mice. Using a pan-Neurofascin-c-terminal (NFct)
antibody, we observed similar levels of nodal Neuro-
fascin186 and paranodal Neurofascin155 protein ex-
pression in wild-type and Whrn knockout mice across
4–16 weeks of age. Examination of neuronal cytoskeletal
protein 4.1B and juxtaparanodal protein Caspr2 shows
steady protein expression levels in wild-type and Whrn
knockout mice from 4–16 weeks of age. Finally, previous
reports showed in vivo interaction between rat Whrn/
CIP98 and calmodulin-dependent serine kinase (CASK)
[27], a synaptic organization protein. After immuno-
blotting for CASK, no difference in its protein level was
observed across Whrn genotype or ages from 4–16 weeks.
Total protein levels in spinal cord lysates were consistent
across the ages and genotypes based on Tubulin levels
(Figure 1E). In summary, these developmental expression
profiles suggest that loss of Whrn expression does not
affect the overall expression or stability of other axonal
domain markers.
Whrn knockout mice reveal a quantifiable paranodal
compaction phenotype in peripheral myelinated axons
To determine the effects of Whrn loss on axonal domain
organization, we examined well-characterized nodal, para-
nodal, and juxtaparanodal markers by immunofluorescence
in wild-type and Whrn−/− mice. Extensive and repeated
immunostaining with our Whrn antibody revealed no
consistent localization or differences in Whrn localization
between wild-type to Whrn−/− fibers (data not shown).
Compared to wild-type, the most striking observation
in teased Whrn−/− sciatic nerve fibers was the spring-like
separation (Figure 1F) of the paranodal axo-glial septate
junction (AGSJ) loops beginning along the paranodal-
juxtaparanodal border as observed by Caspr and NF155
immunostaining. Irregular paranodal compaction is
rarely observed in wild-type fibers, so we sought to
quantify the overall observation of this phenotype in
Whrn+/+ andWhrn−/− fibers. We utilized a blinded counting
strategy to count spring-like phenotypes from wild-type
(N = 4676) orWhrn−/− (N = 2798) Caspr-stained paranodes.
A statistically significant difference (student t-test p = 0.02)
was observed in the percentage of irregular paranodal
compaction at 0.3% (SEM=0.07%) in wild-type fibers
compared to 1.8% (SEM=0.45%) in Whrn knockout
mice. Having confirmed the significance of this spring-
like paranodal phenotype in 7 week-old Whrn knockoutfibers, we expanded our analysis to 4–8 week-old time
points.
Sciatic nerves from Whrn+/+ or Whrn−/− littermate mice
at 4, 6, and 8 weeks, were immunostained with antibodies
against nodal, paranodal, and juxtaparanodal markers
(Figure 2). In the 4 week-old wild-type sciatic nerve
(Figure 2Aa-d), juxtaparanodal Kv1.2 (Figure 2Aa) was
separated from nodal NF186 (Figure 2Ac) by paranodal
Caspr (Figure 2Ab). This demarcation of domains
(Figure 2Ad) in myelinated fibers is also observed
in 4 week-old Whrn−/− fibers (Figure 2Bd). Myelin
loops of AGSJs in 4 week-old Whrn−/− sciatic nerve
fibers (Figure 2Bb) were already separating away from
the paranode compared to 4 week-old wild-type sciatic
nerve fibers (Figure 2Ab). Breaks in Kv1.2 localization
(Figure 2Ba) were observed even where Caspr staining
(Figure 2Bb) was limited to a single myelin loop, sug-
gesting AGSJ’s barrier function was conserved. Jux-
taparanodal localization was diffuse and asymmetric in
Whrn−/− fibers compared to wild-type (Figure 2Aa vs.
2Ba). When comparing wild-type toWhrn knockout mice,
we observed no obvious differences in intensity levels
of juxtaparanodal (Figure 2Aa vs. 2Ba) or nodal (Figure 2Ac
vs. 2Bc) markers. At 6 weeks, teased wild-type sciatic
nerves (Figure 2Ca-d) showed typical domain organiz-
ation. 6 week-old Whrn null sciatic nerves have typical
NF186 (Figure 2Dc) nodal domain organization while
Caspr paranodal compaction (Figure 2Db) and Kv1.2
juxtaparanodal (Figure 2Da) localization were disrupted.
Additional immunostaining in 6 week-old Whrn null
sciatic nerves with a pan-Neurofascin-C-terminal (NFct)
antibody (Figure 2Ea) detected both nodal NF186 and
paranodal NF155. Paranodal NF155 (Figure 2Ea, non-
nodal signal) and Caspr (Figure 2Eb) immunostaining
mostly colocalize (Figure 2Ed) in Whrn−/− sciatic nerve
fibers and revealed similar problems with paranodal
compaction. AnkG nodal (Figure 2Ec) domain organiz-
ation in 6 week-old Whrn−/− sciatic nerve fibers appeared
similar to wild-type (Figure 2Cc). Finally, immunostained
8 week-old sciatic nerves revealed similar NF186 nodal
(Figure 2Fc vs. 2Gc) and AnkG nodal organization
(Figure 2Hc). Like 4 and 6 week-old sciatic nerves,
Caspr (Figure 2Gb, Hb) and NFct (Figure 2Ha) immu-
nostaining consistently revealed paranodal compaction
defects as well as Kv1.2 juxtaparanodal (Figure 2Fa vs.
2Ga) diffusion in Whrn knockout mice when compared
with wild-type (Figure 2Fb). To determine if such
peripheral nerve phenotypes could be the result of
differences in inner mesaxons, we immunostaining
7 week-old wild-type and Whrn knockout fibers with
MAG but observed no striking phenotypic differences
in localization (data not shown). In summary, the
paranodal and juxtaparanodal regions displayed phe-
notypes that suggest that normal compaction of the
Figure 2 Loss of Whirlin in the peripheral nervous system results in disrupted paranodal compaction. A–H. 4, 6, 8-week-old teased sciatic
nerve fibers either wild-type (Aa–Ad, Ca–Cd, Fa–Fd) or Whrn knockout (Ba–Bd, Da–Dd, Ea–Ed, Ga–Gd, Ha–Hd) immunostained against Kv1.2
(Aa-Da, Fa, Ga, red), NFCt (Ea, Ha, red), Caspr (Ab–Hb, green), NF186 (Ac-Dc, Fc, Gc, blue), AnkG (Ec, Hc, blue), and merged images (Ad–Hd). In
all Whrn mutant panels, Caspr (Bb, Bd; Db, Dd; Eb, Ed; Gb, Gd; Hb, Hd, green) and paranodal NF155 (NFCt) (Ea, Ed; Ha, Hd, red) fail to compact
properly at the paranodes. Nodal NF186 or AnkG are not affected (Ac,d–Hc,d, blue). Scale bars (Ad-Hd) = 5 μm. I. Sample image shows
parameters of various domain measurements in (nodal gap in white, paranodal diameter in blue, paranodal width in red, and counting of spring-
like phenotype in purple) using ~10 micron caliber, Caspr-immunostained wild-type and Whrn−/− fibers. J-L. No statistically significant differences
were observed comparing 4, 6, and 8-week-old wild-type and mutant fibers with concern to nodal gap (J), paranodal diameter (K), or paranodal
width (L) (N=20 for each genotype/age combination). Note the greater percentage of paranodes with compaction issues in mutant fibers
(M, light purple bars) likely contributes to the increased deviation in paranodal widths (L, light red bars).
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at 4, 6, and 8 weeks of age.
During initial quantification we observed that larger
diameter myelinated fibers had proportionally more para-
node compaction defects compared to thinner caliber
myelinated fibers, so we imaged and assembled twenty
Caspr-stained confocal images for each genotype and
time point (4, 6, and 8 week-old) to assess any subtle,
sub-micron paranodal changes by light microscopy dueto Whrn loss. Next, we measured various dimensions of
the paranode (Figure 2I). Note images collected were
from ~10 micron caliber myelinated neurons. Using
Zeiss software, micron measurements were recorded,
tabulated, and reported as averages with standard devi-
ations for the nodal gap (Figure 2J), the paranodal
diameter (Figure 2K), paranodal width (Figure 2L), as
well as the percentage of paranodes which display
paranodal compaction abnormalities (Figure 2M). The
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nerves was 0.77±0.16 μm and 0.92±0.24 μm at
4 weeks, 1.01±0.16 μm and 0.91±0.31 μm at 6 weeks,
and 1.06±0.21 μm and 1.00±0.12 at 8 weeks respect-
ively. No statistically significant difference was noted
between ages or genotypes with respect to nodal gap.
The paranodal diameter (Figure 2K) for wild-type
and Whrn−/− sciatic nerves was 2.20±0.42 μm and
2.19±0.41 μm at 4 weeks, 2.33±0.45 μm and 2.43±0.45 μm
at 6 weeks, and 2.14±0.35 μm and 2.71±0.55 at 8 weeks
respectively. With respect to paranodal diameter, measure-
ments were similar between all groups. The paranodal
width (Figure 2L) for wild-type and Whrn−/− sciatic
nerves was 3.45±0.58 μm and 3.52±0.91 μm at
4 weeks, 3.41±0.57 μm and 3.64±1.01 μm at 6 weeks,
and 3.58±0.48 μm and 3.56±0.53 at 8 weeks respect-
ively. No statistically significant difference was found
in paranodal width. The paranodal compaction phenotype
percentage (Figure 2M) for wild-type and Whrn−/− sciatic
nerves was 15% (3/20) and 55% (11/20) at 4 weeks, 15%
(3/20) and 50% (10/20) at 6 weeks, and 15% (3/20) and
55% (11/20) respectively. As a reminder, the increase in
the Whrn knockout phenotype percentage represents the
shift in selection from all fibers (1.8%) to larger-caliber
myelinated fibers (50%). Note the greater percentage
of paranodes with compaction issues in Whrn−/− sciatic
nerves (Figure 2M, light purple bars) likely contributes
to the increased deviation in paranodal widths (Figure 2L,
light red bars). Additionally, comparisons between 8 week-
old wild-type and Whrn−/− sciatic nerve fibers demon-
strated no significant difference in the conduction velocity
(average ~30 m/s) or waveforms (data not shown) of
measured compound action potentials in two separate
measurement trials.
Whrn knockout mouse sciatic nerve and spinal cord
myelinated fibers display paranodal compaction
abnormalities throughout development
To expand on the characterization of Whrn loss with
respect to myelinated domain organization, we examined
a larger developmental window from postnatal ages 2 weeks
to 1 year. Wild-type and Whrn knockout sciatic nerves
revealed the following percentages of Caspr-stained
phenotype-positive paranodes (Figure 2): 1.5% and 2.7%
at 10 weeks, 0.9% and 1.8% at 20 weeks, 0.8% and 1.5%
at 30 weeks, 0.5% and 1.4% at 40 weeks, and 0.7% and
1.5% at 1 year, respectively. Similar to the 4–8 week
studies (Figure 2), we immunostained fibers with nodal,
paranodal, and juxtaparanodal markers, as well as the
axonal cytoskeletal protein markers 4.1B and heavy chain
Neurofilament (Nfl-H) given Whrn’s known cytoskeletal
scaffolding role. We observed no differences in nodal
formation using NF186 (Figure 3Ac, Bc) in 2 week-old
fibers. Abnormalities in paranodal formation and com-paction were observed in Caspr-stained Whrn−/− fibers
(Figure 3Bb, Bf) compared to wild-type (Figure 3Ab, Af).
Overall Kv1.2 juxtaparanodal signal appeared similar
between 2 week-old wild-type (Figure 3Aa) and Whrn−/−
fibers (Figure 3Ba) with accumulation and enrichment
of Kv1.2 channels (Figure 3Bd) neighboring Caspr
within the internodal region. No obvious difference in
intensity or localization of Nfl-H (Figure 3Ae, Be) or
4.1B (Figure 3Ag, Bg) was found in 2 week-old sciatic
nerve fibers between Whrn genotypes. With 10 week-old
sciatic nerve fibers, we observed no differences in nodal
domains using NF186 (Figure 3Cc, Dc). Like 8 week-old
fibers (Figure 2F-H), we observed 10 week-old Whrn−/−
fibers with abnormal paranodal compaction (Figure 3Db,
Df), when compared to wild-type fibers (Figure 3Cb, Cf).
Juxtaparanodal domains stained with Kv1.2 (Figure 3Da vs.
3Ca) appear more diffuse but similar in overall intensity
in 10 week-old Whrn−/− fibers when compared to wild-
type. We observed slight enrichment of Nfl-H (Figure 3Ce
vs. 3De) and 4.1B (Figure 3Cg vs. 3Dg) within the
paranodal region of 10 week-old wild-type sciatic nerves
compared to Whrn knockout mice, but the overall inten-
sity of Nfl-H and 4.1B along the remaining axon appeared
similar. Immunostaining of 20, 30, and 40 week-old
wild-type sciatic nerve fibers were performed and domain
organization was identical to 10 week-old wild-type
fibers (Figure 3Ca-k). Looking at 20, 30, and 40 week-
old Whrn−/− peripheral nerve fibers, we observed no
differences in nodal domains between Whrn wild-types
(Figure 3Cc) or knockout mice using NF186 (Figure 3Ec-
Gc). Similar to 10 week-old fibers (Figure 3Db, Df ), we
observed numerous 20, 30, and 40 week-old Whrn null
fibers stained with Caspr (Figure 3Eb,d-Gb,d) with ab-
normal paranodal compaction when compared to wild-
type fibers (Figure 3Cb,d). In 20, 30, and 40-week old
Whrn−/− fibers, juxtaparanodal domains stained with
Kv1.2 (Figure 3Ea-Ga) showed numerous breaks at sites
of Caspr signal, appeared less symmetrical, and dis-
played similar overall signal when compared with wild-
type (Figure 3Ca). Cytoskeletal marker Nfl-H staining
(Figure 3Ee-Ge) was generally uniform within the axon,
and 4.1B (Figure 3Eg-Gg) was present in all axonal
domains except the node in 20, 30, and 40 week-old
Whrn−/− sciatic nerves. One-year-old sciatic nerves
showed no difference in nodal organization (Figure 3Hc
vs. 3Ic). One year-old Whrn−/− sciatic nerves (Figure 3Ib,
d) revealed abnormal paranodal compaction compared to
wild-type fibers (Figure 3Hb,d). Notably, we observed
paranodal compaction defects in older Whrn−/− sciatic
nerve fibers (40 week-old and 1 year-old) like blocks
and bulges in Caspr signal as well as the spring-like
phenotype observed in younger fibers (4–30 week-old).
As seen previously, the juxtaparanodal domains of
Whrn−/− peripheral nerves stained with Kv1.2 (Figure 3Ia)
Figure 3 Loss of Whirlin contributes to abnormal paranodal compaction and cytoskeleton instability throughout sciatic nerve age. A–I.
2-week, 10, 20, 30, 40-week, and 1-yr-old teased sciatic nerve fibers either wild-type (Aa–Ah, Ca–Ch, Ha–Hh) or Whrn knockout (Ba–Bh, Da–Dh,
Ea–Eh, Fa–Fh, Ga–Gh, Ia–Ih) immunostained against Kv1.2 (Aa-Ia, red), Caspr (Ab,f–Ib,f, green), NF186 (Ac-Ic, blue), heavy chain Neurofilament/
Nfl-H (Ae-Ie, red), Protein 4.1 band/4.1B (Ag-Ig, blue), and merged images (Ad,h–Hd,h). In all Whrn mutant panels, Caspr (Bb,d,f,h; Db,d,f,h; Eb,d,
f,h; Fb,d,f,h; Gb,d,f,h, Ib,d,f,h, green) fail to compact properly at the paranodes while juxtaparanodal marker Kv1.2 (Ba,Bd; Da,Dd; Ea,Ed; Fa,Fd; Ga,
Gd; Ia,d, red) appears diffuse and disorganized. Nodal NF186 (Ac-Ic, blue) appear unaffected by genotype or age. Cytoskeletal markers like Nfl-H
(De-Ge vs. Ce, Ie vs. He, red) and 4.1B (Dg-Gg vs. Cg, Ig vs. Hg, blue) show more diffusion and irregularities in intensity, particularly older
animals, in Whrn mutant nerves compared to wild-type nerves, suggesting Whrn contributes to paranodal cytoskeletal stability. Scale bars
(Ad-Id, Ah-Ih) = 5 μm. Further quantification and percentages of phenotype-positive sciatic nerves is included for each age/genotype in a
summary graph (bottom).
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odic breaks as well as overlap with Caspr signal when
compared with one year-old wild-type fibers (Figure 3Ha).
Also, patchy cytoskeletal-deficient staining was observed
in older Whrn−/− fibers (Figure 3Gh, 3Ih) near the para-
node. Cytoskeletal marker Nfl-H staining was weakly
enriched within the paranode of the wild-type axon
(Figure 3Hh) and less uniform within Whrn−/− fibers with
paranodal compaction problems (Figure 3Ih). Likewise,
4.1B showed disrupted juxtaparanodal cytoskeletal
staining in one year-old Whrn−/− fibers (Figure 3Ig) which
was not observed in the wild-type fibers (Figure 3Hg).
We also sought to examine the effects of Whrn loss
on axonal domain organization in the central nervous
system (CNS). Utilizing white matter tracts in the spinal
cord, we were able to identify by immunostaining subtle
but consistent differences in paranodal compaction. As
in the PNS (Figure 3), we stained longitudinal spinal
cord sections with nodal, paranodal, and juxtaparanodal
markers (Figure 4). Wild-type and Whrn knockout spinalcord fibers revealed the following percentages of Caspr-
stained phenotype-positive paranodes (Figure 3): 0.6%
and 1.7% at 10 weeks, 1.2% and 3.4% at 20 weeks, 1.3%
and 2.5% at 30 weeks, and 1.0% and 2.4% at 40 weeks.
No differences in nodal organization were observed
(Figure 3.4Ac vs. 3.4Bc) in 2 week-old spinal cord
sections. At 10, 20, 30, 40 week-old, nodal organization
appeared similar between wild-type and Whrn−/− spinal
cord fibers using NF186 (Figure 4Cc vs. 4Dc, 4Ec vs.
4Fc, 4Gc vs. 4Hc, 4Ic vs. 4Jc). Immunostaining with
paranodal Caspr revealed subtle and infrequent para-
nodal abnormalities in 2 week-old Whrn null spinal cord
fibers (Figure 4Bb) compared to wild-type (Figure 4Ab).
In contrast, obvious and regular paranodal compaction
defects were observed in 10 (Figure 4Cb vs. 4Db), 20
(Figure 4Eb vs. 4Fb), 30 (Figure 4Gb vs. 4Hb), and
40 week-old (Figure 4Ib vs. 4Jb) Whrn−/− spinal cords
compared to their wild-type controls. Finally, juxta-
paranodal Kv1.2 immunostaining of 10 (Figure 4Ca vs.
4Da), 20 (Figure 4Ea vs. 4Fa), 30 (Figure 4Ga vs. 4Ha), and
Figure 4 Loss of Whirlin contributes to abnormal paranodal compaction throughout development in the spinal cord. A–J. 2-week,
10, 20, 30, 40-week teased sciatic nerve fibers either wild-type (Aa–Ad, Ca–Cd, Ea–Ed, Ga–Gd, Ia–Id) or Whrn knockout (Ba–Bd, Da–Dd, Fa–Fd,
Ha–Hd, Ja–Jd) immunostained against Caspr (Ac–Jc, green), Kv1.2 (Aa–Ja, red), NF186 (Ac–Jc, blue), and merged images (Ad–Jd). Nodal NF186
(Ac–Jc, blue) appear unaffected by age or genotype. In Whrn mutant spinal cords, Caspr (Bb,d; b,d; Fb,d; Hb,d; Jb,d; green) does not compact
properly at the paranodes compared to wild-type Caspr (Ab,d; Cb,d; Eb,d; Gb,d; Ib,d; green). In addition, juxtaparanodal marker Kv1.2 (Ba,d; Da,d;
Fa,d; Ha,d; Ja,d; red) in Whrn mutant spinal cords shows similar signal intensity and occasional colocalization with Caspr-stained myelin loops.
Scale bars (Ad–Jd) = 5 μm. Further quantification and percentages of phenotype-positive spinal cord fibers is included for each age/genotype in
a summary graph (bottom).
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myelinated axons showed similar overall expression as
Whrn knockout axons, but consistent juxtaparanodal
disorganization and colocalization with loosened Caspr-
stained myelin loops was observed most often in Whrn−/−
fibers. In summary, there is significant evidence that loss
of Whrn disrupts normal paranodal compaction in 10–
40 week-old myelinated spinal cord axons with subsequent
effects on juxtaparanodal organization. Taken together,
both the peripheral and central nervous systems likely
utilize the cytoskeletal properties of Whrn to help
stabilize the cellular organization between myelinatingglial cells and neurons around the paranodal region
throughout development.
Whirlin knockout mice have cerebellar Purkinje cells with
bead-like, axonal swellings
To determine the effects of Whrn loss on cerebellar
Purkinje cell morphology, we immunostained cerebellar
slices from 6 week-old wild-type, Whrn knockout, and
double Whrn and 4.1B [14] null animals (Figure 5).
Given that Caspr [9] and CGT [28,29], two genes critical
for formation of a proper paranode, display Purkinje
axonal swellings and cytoskeletal disorganization, we
Figure 5 Whirlin alone and combination 4.1B/Whirlin knockout mice have cerebellar Purkinje cells with bead-like, axonal swellings.
A–D. 6-week sagittal sections of mouse cerebellum in either wild-type (Aa–Af), Whrn knockout (Ba–Bf), or double Whrn knockout and 4.1B null
(Ca–Cf, Da–Df) immunostained against Protein 4.1B band/4.1B (Aa–Da, Ad–Dd, red), Calbindin (Ab–Db, green), myelin basic protein/MBP
vAe–De, green), and merged images (Ac,f–Dc,f). No striking difference was observed between wild-type and Whrn knockout slices in 4.1B
staining (Aa,d vs. Ba,d) and only non-specific staining was present in 4.1B null animals (Ca–Da, Cd–Dd). In Whrn mutant cerebellum sections
(Ba–Bf), Purkinje axonal swellings appear bead-like using both Calb (Bb,c vs. Ab,c) and MBP (Be,f vs. Ae,f) in comparison to a uniform, thin
caliber axon in wild-type fibers (Aa–f). Additionally, secondary ablation of 4.1B protein resulted in a greater number of swellings observed with
Calb (Cb,c–Db,c vs. Bb,c) and MBP (Ce,f–De,f vs. Be,f) when compared with Whrn knockouts alone suggesting these cytoskeletal elements help
prevent cytoskeletal disorganization in Purkinje cell axons. Scale bars (Ac–Dc, Af–Df) = 10 μm.
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Whrn and 4.1B. While no obvious differences in local-
ization was observed using our Whrn antibody (data not
shown) in any of these genotypes, we immunostained
against 4.1B (Figure 5Aa,d–Da, d; red), Purkinje-specific
Calbindin (Figure 5Ab–Db, green), and glial-specific
myelin basic protein/MBP (Figure 5Ae–De, green). There
was no difference in 4.1B staining intensity (Figure 5Aa,
d vs. 5Ba,d) between wild-type and Whrn knockout
slices. Upon examining Whrn−/− cerebellum sections
(Figure 5Ba–Bf ), Purkinje axons appeared to contain
bead-like, swellings along their extensions through the
granular layer using both Calb (Figure 5Bb,c vs. 5Ab,c,
white arrowheads) and MBP (Figure 5Be,f vs. 5Ae,f,
white arrowheads) in comparison to a uniform caliber
axon in wild-type fibers (Figure 5Ab,c,e,f ). The second-
ary loss of 4.1B protein resulted in more swellings ob-
served with Calb (Figure 5Cb,c–5Db,c vs. 5Bb,c, white
arrowheads) and MBP (Figure 5Ce,f–5De,f vs. 5Be,f,
white arrowheads) when compared with Whrn null ani-
mals alone. In summary, the cytoskeletal elements Whrn
and 4.1B likely have an assistive role in preventing cyto-
skeletal accumulation and disorganization within cere-
bellar Purkinje cell axons in a similar phenotypic
manner to Caspr null mice [9].Ultrastructural abnormalities in Whrn knockout sciatic
nerve, spinal cord fibers, and cerebellar Purkinje axons
To further understand Whrn’s role in myelinated axons,
transmission electron microscopy was performed in order
to examine the ultrastructural architecture in myelinated
axons in the PNS (Figure 6) and CNS (Figure 7) of
7 week-old and 3 month-old wild-type and Whrn−/−
mice. Low-magnification, cross-section electron micro-
graphs of wild-type (Figure 6A) and Whrn knockout
(Figure 6B, C) myelinated sciatic nerve fibers showed
the typical organization of tightly bound, electron-
dense myelin wraps around the internodal region of the
axonal membrane. Accumulation of mitochondria and
lipid vesicles (Figure 6B, C vs. 6A and 6E, F vs. 6D, flat
arrowheads) in the internodal regions was clearly observed
in Whrn knockout animals compared to wild-type sciatic
nerve fibers. Given the potential role of the mesaxon in
the observed light microscope phenotype [15], we found
no striking differences in the ultrastructural organization
or arrangements of the inner mesaxon along the inter-
nodal region at 7 weeks or 3 months of age (data not
shown). Consistent with our immunostaining data, no
obvious differences in nodal organization were observed
in either genotype (Figure 6G vs 6H,I). Higher magnifi-
cation along the wild-type paranodal region (Figure 6J,
Figure 6 Ultrastructural examination of Whirlin knockout sciatic nerves reveals organelle accumulation and cytoskeletal disruption.
Low magnification electron micrographs through the internodal regions of sciatic nerves in wild-type (7 week-old) and Whrn knockout mice
(7 week-old, 3 month-old) in cross section (A vs. B, C) and longitudinal orientations (D vs. E, F). Overall cellular organization between Whrn
knockout and wild-type sciatic nerve fibers is conserved with tightly compacted myelin around each axon. Low magnification, longitudinal
electron micrographs through the nodal and paranodal regions of sciatic nerves are presented for wild-type (7 week-old, G) and Whrn knockout
mice (7 week-old, H; 3 month-old, I). At a higher magnification, the wild-type (J) paranodal loops have clearly defined characteristic transverse,
electron-dense septa (concave arrowheads) and parallel arrays of cytoskeletal elements. In contrast, Whrn mutant paranodal septa (K, L,
concave arrowheads) are less definitive and fuzzy with associated accumulation of organelles (flat arrowheads), particularly mitochondria and
transport vesicles. Scale bars: A–I, 2 μm, J–L, 400 nm.
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dense AGSJs formed between the glial paranodal loops
and axolemma and accompanying parallel arrays of
cytoskeletal elements in the axon. In contrast, the Whrn
knockout paranodal region of 7 week-old (Figure 6K) and3 month-old (Figure 6L) displayed poorly defined but
present AGSJs (Figure 6K,L, concave arrowheads), less
organized neurofilaments and microtubules, and con-
sistent accumulation of mitochondria and lipid vesicles
(Figure 6H, 6I, 6L, flat arrowheads) in the paranodal
Figure 7 Ultrastructural examination of Whirlin knockout central nervous system tissues reveals organelle accumulation in myelinated
axons. Electron micrographs of internodal cross sections (A–C) and nodal-paranodal longitudinal (D–F) regions in spinal cords from wild-type
(7 week-old, A, D) and Whrn knockout mice (7 week-old, B, E; 3 month-old, C, F). Overall cellular organization is conserved between wild-type
and Whrn knockout and sciatic nerve fibers with tightly compacted myelin around each axon. Enrichment of mitochondria (flat arrowheads)
and occasional myelin ruffling is observed in Whrn knockout mice compared to wild-type. At higher magnification, the wild-type (G) paranodal
loops have characteristic electron-dense septa (concave arrowheads) and parallel arrays of cytoskeletal elements. In contrast, Whrn knockout
CNS fibers accumulate organelles (flat arrowheads), particularly mitochondria and transport vesicles, and have paranodal septa (H, I, concave
arrowheads) that are less defined. Also, electron micrographs from mice show cerebellar Purkinje myelinated axons (J–L) running through the
granular layer. This region reveals axonal swellings filled with densely-packed organelles (flat arrowheads), particularly mitochondria and vesicles,
in 7 week-old (K) and 3 month-old (L) Whrn knockout animals compared to 7 week-old wild-type (J). Scale bars: A–F, 2 μm, G–I, 400 nm, J–L:
1 μm.
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7 weeks and 3 months of age suggest that Whrn is im-
portant for the long-term maintenance and the overall
structure of the myelinated axons.
In the central nervous system, low-magnification, elec-
tron micrographs of wild-type (Figure 7A) and Whrn
knockout (Figure 7B, C) myelinated fibers showed slight
differences in spinal cord cross-sections. Like the periph-
eral nerves, the overall organization between glial cell
and neuron remained similar between wild-type and
Whrn−/− fibers. However, mitochondria were slightly more
abundant in Whrn knockout fibers. No obvious ultra-
structural differences were observed in the node of either
genotype (Figure 7D-F), but greater accumulation of mito-
chondria (flat arrowheads) and lipid vesicles was observed
in the paranodal and juxtaparanodal regions. Higher
magnification along the paranodal region (Figure 7G-I,
concave arrowheads) revealed the expected electron-dense
AGSJs formed between myelin loops and the axolemma.
Like in the PNS, the Whrn knockout paranodal region
of 7 week-old (Figure 7H) and 3 month-old (Figure 7I)
displayed poorly defined but present AGSJs (concave
arrowheads) and accumulation of mitochondria and lipid
vesicles (Figure 7H, flat arrowhead) in the paranodal re-
gion. Examining the cerebellum, we observed Purkinje
axon swellings in Whrn knockout fibers (Figure 7K-L).
Low-magnification electron micrographs of 7 week-old
wild-type (Figure 7J) and Whrn knockout at 7 weeks
(Figure 7K) and 3 months (Figure 7L) of age showed
striking differences in Purkinje axon myelinated fibers
in the cerebellum granular layer. This region shows
axonal swellings filled with densely-packed organelles,
particularly mitochondria and vesicles (Figure 7K-L, flat
arrowheads). Taken together, the ultrastructural analyses
of Whrn knockout mice demonstrate that Whrn is critical
for the stability of paranodal organization, proper axonal
cytoskeletal arrangements, and prevention of sub-cellular
organelle accumulation in myelinated axons.
Conclusions
Cellular and molecular interactions between neurons
and glia establish and stratify the numerous tasks of the
nervous system. In particular, linkage of cellular mem-
branes with the underlying cytoskeleton via cytoskeletal
linker proteins helps maintain the specialized cellular
arrangements necessary to glial and neuronal function.
The potential of Whrn to link plasma membrane proteins
with multiple cytoskeletal protein partners has been well
established [16,17,19-24], yet a precise role for Whrn in
the central or peripheral nervous system or even more
specifically in myelinated neurons has not been examined.
In myelinated axons, axonal membrane proteins like
Caspr and Caspr2 help stabilize domain organization
through linkage of 4.1B to the underlying cytoskeleton.This loss of organization at both the light and electron
microscopy level is readily apparent in mutant mice
lacking Caspr [7], Caspr2 [12], and 4.1B [14]. Here we
report that Whrn knockout animals reveal defective
cytoskeletal organization and accumulation of organelles
in the myelinated fibers. Our phenotypic analyses of Whrn
knockout mice demonstrate that loss of Whrn disrupts
proper paranodal compaction and long-term stability of
the myelinated axons throughout development.
Whrn alternative splicing and phenotypes
To understand the function of Whrn in the nervous sys-
tem, one must be considerate of Whrn mRNA splice
variants and rule out confounding mouse genetic strain
differences. Currently, two mutant mouse strains exist
for Whirlin: the whirler (Whrnwi/wi) mouse has a spon-
taneous genomic deletion of exons 6–9 while the Whrn
(Whrn−/−) knockout mouse [17] has a targeted exon 1
deletion. We examined the localization of several mye-
linated axon markers (Caspr, 4.1B, Kv1.2, and NF186) in
Whrn wild-type mice from each background strain and
observed no disruptions in the localization of these
proteins or the morphology of the paranodes (data not
shown). Our initial studies comparing Whrn−/− to Whrnwi/wi
mouse strains suggested myelinated domain organization,
early paranodal disorganization, and nerve conduction
(~30 m/s) was indistinguishable between each mutant
mouse line. Given the novelty of the phenotype, we
additionally substantiated no mouse strain effects after
back-crossing to isogenic C57BL6 mice for two genera-
tions. Given the consistency of the mutant phenotype
regardless of background mouse genetics, we were assured
the phenotype was attributed to loss of Whrn function
and not alternative Whrn splice variants or mouse genetic
background variation.
Scaffolding by Whrn and previously established protein
networks may underlie paranodal compaction
and stabilization
Whrn has several established roles derived from its
complex and numerous interactions with other protein
partners within the ear and eye. This complexity comes
from identifying and comparing the human and mouse
Whrn mutants and splice variants. The significant bulk
of Whrn research has been performed in the ear and
eye since human WHRN mutations contribute to a sub-
set of Usher syndromes. In the eye, full-length Whrn
colocalizes with the transmembrane proteins Usherin
and VLGR1 at the periciliary membrane complex in
photoreceptors [17]. Studies demonstrate the two N-
terminal PDZ domains of the full-length Whrn isoform
are responsible for this interaction. In the ear, the
shorter Whrn isoform has a more significant role since
mutation and/or loss of Whrn’s C-terminus correlates
Green et al. BMC Neuroscience 2013, 14:96 Page 13 of 17
http://www.biomedcentral.com/1471-2202/14/96to poorer hearing deficits compared to Whrn’s N-terminus.
The Whrn short isoform interacts through its Proline-
rich domain and last PDZ domain with Myosin XVa
and Mpp1/p55. Additional reports demonstrate Whrn
protein expression in the mouse cerebrum, cerebellum,
and brainstem [25], rat cerebellum [27], and in the
Drosophila central nervous system [26]. Taken together,
Whrn has a well-documented history of shared protein-
protein interaction across multiple model systems and cells.
We propose that Whrn as a cytoskeletal scaffold
crosslinks a subcellular axonal meshwork to stabilize the
paranode, juxtaparanode, or both, and that in the ab-
sence of Whrn, subcellular compaction of the paranode
and organization of underlying microtubules, neurofila-
ments, cause cytoskeletal disorganization leading to an
accumulation of mitochondria, and lipid vesicles along
myelinated axons. Here we propose the potential sites
of interaction for Whrn within these regions given its
established protein-protein interactions in vivo. Within
the paranode, the intracellular c-terminus of Caspr
contains a SH3 domain, a potential site of interaction
with Whrn’s Proline-rich domain. The paranode and
juxtaparanode are also enriched for 4.1B, a known pro-
tein partner in the ear stereocilia for Mpp1/p55 which
interacts with Whrn [22]. Caspr2 also contains a PDZ-
binding motif which could potentially interact with one
of Whrn’s PDZ domains [12]. Finally, the c-terminus of
Whrn has the potential for self-oligomerization [20],
allowing for even more complex networks of protein-
protein interaction within the myelinated axon.
Domain organization in myelinated axons is a compli-
cated developmental process, culminating from intrinsic
and extrinsic cellular factors. Here we demonstrate that
Whrn expression is important for proper axonal domain
organization and expand the role of Whrn outside the
ear and eye. The phenotypes observed in the myelinated
axons highlight that the paranodal-juxtaparanodal in-
terface represents a substantial region for insight into
paranodal stabilization and potential interaction with the
axonal cytoskeleton. In light of recent evidence of 4.1G’s
role at the internode and mesaxon, this paranodal-jux-
taparanodal interface may represent an important sub-
domain in the study of myelinated fibers. Whrn’s protein
domains have the potential to stabilize the paranodal
myelin loops and associated cytoskeleton through direct
or indirect interactions with Caspr, 4.1B, or other un-
identified cytoskeletal proteins. These observations are
correlated using several techniques including biochemis-
try, light and electron microscopy. Our observed para-
nodal phenotypes are consistent throughout development
(2 wk-1 yr) and similar between central and peripheral
nervous systems. One final important consideration
about cytoskeletal linker proteins, both Whrn and 4.1B
null mice have no statistical difference in conductionvelocities in sciatic nerves compared to wild-type mice,
despite having clear paranodal instability in Caspr-stained
myelinated fibers. Such data suggest cytoskeletal linker
proteins may be functionally redundant with respect to
myelinated domain organization and may require second-
ary or tertiary genetic ablations to achieve any measurable
electrophysiological effects. To this point, we observed the
increase in Purkinje axonal swellings in the double Whrn;
4.1B null mouse cerebellum compared to the single Whrn
knockout or wild-type mouse cerebellum. In conclusion,
our observations indicate Whrn acts as a cytoskeletal
scaffolding protein that is essential for proper paranodal
compaction and stabilization of the axonal cytoskeleton
for long-term health of myelinated axons.
Methods
Animals
Whrn exon 1 homozygous mutants used were obtained
from Dr. Jun Yang’s lab (University of Utah, Salt Lake
City, Utah, 84132). The mice were backcrossed to
C57BL6 mice (JAX Laboratories #000664, Bar Harbor,
Maine) for two generations and maintained as heterozy-
gous Whrn+/− breeding stocks. All animal experiments
were performed according to Institutional Animal Care
and Use Committee approved guidelines for ethical
treatment of laboratory animals at the University of
North Carolina at Chapel Hill and the University of
Texas Health Science Center at San Antonio.
Genotyping
Genomic DNA from mouse tails and/or toe snips was
extracted using a kit according to manufacturer’s in-
structions (Sigma-Aldrich Extract-N-Amp™ Tissue PCR
Kit (XNAT2)). Cycling conditions used were: 95°C for
5 min, 35 cycles of (95°C for 30 sec, 68°C for 1.5 min),
and 68°C for 3 min. Primer sequences for PCR were
obtained from Dr. Jun Yang’s lab as follows: common
WhrnRP (Pdzg5r) CAGGGAAGTTGAGGCACACGG,
wild-type Whrn+FP (pdzg1) GGGTGAGTGAATGCCA
GCCAG, and knockout Whrn-FP (PNT3A) GAGATCA
GCAGCCTCTGTTCCAC. The Whrn+ product size is
894 bp; the Whrn- product size is 700 bp.
Generation of Whrn antibody
We generated rabbit, guinea pig, and rat polyclonal anti-
Whrn antibodies similar to previous literature [23]. A
full length Whrn mouse cDNA construct in pcDNA3.1
was obtained from Dr. Jun Yang’s lab. Regions encoding
amino-acid residues 220–326 and 699–804 of mouse
Whirlin (Genbank: NP_001008791.1) were subcloned in-
dividually into pGEX4T1 and expressed in Escherichia
coli (BL21; Stratagene, La Jolla, CA). Fusion proteins
were isolated by incubating with Glutathione Sepharose
4 Fast Flow (GE Healthcare, Sweden). Each fusion
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rat (Cocalico Biologicals Inc, Reamstown, PA). cDNAs en-
coding amino acids 220–326 or 699–804 of mouse Whrn
were also introduced into pMAL-c2x (New England
Biolabs, Beverely, MA), transformed into E. coli (DE3
BL21; Stratagene) and induced to express the correspond-
ing maltose binding (MBP) fusion protein. The expressed
MBP-fusion proteins were purified using amylose resin
(New England Biolabs, Beverely, MA) and then linked to a
NHS-activated Sepharose 4 Fast Flow (GE Healthcare,
Sweden). Only antisera from the immunized rabbit #349
(RbWhrn349) was affinity purified using the correspond-
ing MBP–Whrn fusion protein.RNA preparation and RT-PCR
Sciatic nerves, dorsal root ganglia, and spinal cord sections
were removed from p21Whrnmutant and wild-type mice.
Tissue was stored and processed in RNAlater Stabilization
Reagent (QIAGEN). Total RNA was isolated using QIA
shredder columns (QIAGEN) and RNeasy Mini Kit
(QIAGEN). RNA concentration was estimated and ap-
prox. 5 ng RNA was used for reverse transcription
followed by PCR amplification using the MyTaq One-Step
RT-PCR kit (Bioline). RT-PCR analysis was performed on
three separate sets of animals. Cycling conditions used
were: 45°C for 20 min, 95°C for 1 min, 35 cycles of (95°C
for 10 sec, 62°C for 10 sec, 72°C for 30 sec), and 72°C
for 5 min. Primers used for PCR were as follows: Actin
(Ex2) FP: GCTCCGGCATGTGCAA, Actin (Ex4) RP: A
GGATCTTCATGAGGTAGT. Whrn (Ex1) FP: ACCA
GATTCTGCGCGTCAAC, Whrn (SalI-Ex4) RP: tccgG
TCGACcacctccagaatctggtctc; Whrn (EcoRI-Ex9) FP: CC
CAgaattcGGGGCCTGCCTTCCACC, Whrn (SalI-Ex10)
RP: cgggGTCGACgttggcaccctccgcgg.Other antibodies and immunostaining reagents
The following antisera were previously described: guinea
pig and rabbit anti-Caspr [7,10,30], guinea pig anti-
NF186 and guinea pig anti-pan Neurofascin [10,30],
guinea pig anti-4.1B antibodies [14], and mouse anti-
Calbindin [31]. Other primary antibodies used include the
following: mouse anti- Kv1.2 (University of California
Davis/NIH NeuroMab Facility; K14/16), mouse anti-
CASK (University of California Davis/NIH NeuroMab
Facility; K56A/50), mouse anti-Ankyrin G (University
of California Davis/NIH NeuroMab Facility; N106/36),
mouse anti-Neurofilament H (Chemicon, MAB1623),
rabbit anti-alpha-Tubulin (Cell Signaling #2144) and
anti-Myelin Basic Protein (Abcam, SMI-94). Secondary
antibodies used for immunofluorescence were Alexa
Fluor-488, -568, and −647 conjugated (Invitrogen). HRP-
conjugated secondary antibodies were purchased from
Jackson ImmunoResearch.Immunostaining
Briefly, sciatic nerves were removed from anesthetized
littermate wild-type and Whrn mutants of either sex and
fixed in 4% paraformaldehyde in PBS for 15–30 min.
The nerves were washed with PBS three times (10 min
each) and stored at 4°C until teased. The nerves were
teased into individual fibers in PBS, mounted on glass
slides, and dried overnight at room temperature. Fibers
were either immediately used for immunostaining or
stored at −80°C until needed. Teased nerve slides were
submerged in acetone (methanol instead for anti-MBP
staining) at −20°C for 20 min then washed with PBS,
followed by immunostaining [4]. For spinal cord sections
and cerebellar sections, wild-type and mutants were
deeply anesthetized and intra-cardially perfused with
PBS followed by ice-cold 4% paraformaldehyde in PBS.
The spinal cord or cerebellum was dissected out and
post-fixed in 4% paraformaldehyde overnight at 4°C. The
tissues were rinsed with PBS and sectioned to 30 um
using a Vibratome (Leica). The sections were then im-
mediately immunostained as previously described [9,10].
Primary antibodies for immunostaining were used at the
following concentrations overnight at 4°C: RbCaspr @1:500,
GPNF186 @1:400, MsIgG2b- Kv1.2 @1:200, GPNFCt
@1:400, GP-beta-IVspectrin @1:1000, GP4.1B @1:10000,
and MsIgG-Nfl-H @1:1000, MsIgG1-Calb @1:1000, and
MsIgG1-MBP @1:200.
Immunoblotting
Sciatic nerves and dorsal root ganglia from littermate
wild-type and mutants of either sex were excised and
processed using a glass homogenizer in ice-cold lysis
buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl,
10 mM EDTA, 1% Triton X-100, 1% SDS, and a protease
mixture tablet). The lysate was incubated for 30 min on
ice and then centrifuged at 16,000×g for 20 min at 4°C.
The sciatic nerve or dorsal root ganglia supernatant was
saved for further processing. Spinal cords from litter-
mate wild-type and mutants of either sex were excised
and either directly processed or frozen at −80°C. Spinal
cords were homogenized using a glass mortar and pestle
on ice with lysis buffer (50 mM Tris–HCl, pH 7.5,
150 mM NaCl, 10 mM EDTA, 1% Triton X-100, and a
protease inhibitor mixture tablet) and incubated for
30 min on ice with occasional trituration. The homogen-
ate was centrifuged at 1000xg for 10 min at 4°C. The
supernatant was collected and subjected to an additional
centrifugation at 100,000 × g for 30 min at 4°C. The
resulting second supernatant was collected and saved for
further processing. Protein concentrations of final lysates
were determined using the Lowry assay (BC assay; Bio-
Rad). Lysates were resolved by SDS-PAGE and transferred
onto nitrocellulose membranes, followed by immuno-
blotting procedures described previously [4]. Primary
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concentrations for 1 hr at room temperature: Affinity-
purified RbWhrn349 @ 1:1000 (overnight at 4°C), GP
Caspr @ 1:2000, GPNFCt @ 1:2000, Rb4.1B @ 1:50000, Ms
IgG1-CASK @ 1:50000, RbCaspr2 @ 1:50000, RbTubulin
@ 1:2000 (overnight at 4°C).
Electrophysiology
The conduction velocity measurements of sciatic nerves
were carried out on three separate wild-type (+/+) and
Whrn−/− mice as described previously [10,30].
Image analysis and software
Confocal images were captured with a Zeiss LSM510
microscope. Scanning parameters were optimized for
wild-type tissues and maintained for scanning the mutant
tissues. Immunofluorescence images for sciatic nerves and
spinal cords are composite projections from Z stacks of
three to six sections (0.6um scan step) or stacks of ten to
twenty sections (0.6um scan step) for cerebellar slices.
Software used for assembling figures included Zeiss LSM
Image Browser (v4.2), ImageJ (v1.47d), GIMP (v2.82), and
OpenOffice (v3.4.1).
Quantification of phenotype and statistics
For the initial quantification, we utilized a blinded count-
ing strategy to best estimate the spring-like phenotype.
Teased sciatic nerves were prepared from wild-type or
Whrn−/− mice. One individual prepared all teased slides
and randomly assigned a number to each slide. Once
completed, the individual compiled a table of genotypes
matched to assigned numbers. Blinded to that table, a sec-
ond individual immunostained the numbered slides and
counted wild-type and Whrn−/− Caspr-stained paranodes.
Immunostained paranodes were counted under a fluores-
cent microscope at 40× magnification. Any paranode with
3 or more spring-like, loops were considered phenotype-
positive. Data was compiled as the percentage of pheno-
type-positive paranodes out of total paranodes. Phenotype
percentages per slide were matched to genotype and
then a final average phenotype percent for wild-type or
Whrn−/− fibers was calculated as well the standard
error of the mean (SEM). A standard t-test was used to
calculate the statistical significance (p-value) between
the percent for 7 week-old wild-type or Whrn−/− fibers.
Similar phenotype quantitation was applied to 10, 20,
30, and 40 wk old sciatic nerve and spinal cords. All
measured data was tabulated in Microsoft Excel. A p-
value of 0.05 was considered to indicate a significant
difference between groups.
For secondary quantitation of paranodal parameters in
4–8 week-old animals, Caspr-stained paranodes were
imaged using a confocal LSM510 microscope and accom-
panying Zeiss Image software. A composite projection ofZ-stacks was performed for each image. Large-caliber
sciatic nerve images (~10um total diameter glial-edge to
glial edge) were analyzed given the initial observation
of more phenotype-positive paranodes in large vs. small
caliber axons. Twenty wild-type and twenty Whrn−/−
paranode images were selected for each time point (60
total images). Using Zeiss software tools, each paranode
was measured in microns for nodal gap (distance between
nodal-paranodal boundaries in white), paranodal diameter
(distance across axon caliber in blue), paranodal width
(distance from nodal-paranodal boundary to paranodal-
juxtaparanodal boundary in red), and phenotype percent-
age (a paranode was considered phenotype-positive if
the purple line from the paranodal-juxtaparanodal bound-
ary crossed a Caspr AGSJ line three times (i.e. 1.5 circular
myelin wrapping loops) and phenotype-negative if less
than three times). All measured data was tabulated in
Microsoft Excel. The average and standard deviation of
each age and genotype was graphed for nodal gap,
paranodal diameter, and paranodal width. Phenotype
percentage was reported as a percent of phenotype-
positive paranodes out of twenty total counted for that
age and genotype.Transmission electron microscopy
Animal tissues were fixed using 4% Formaldehyde/1%
Glutaraldehyde (4CF1G) via intra-cardiac perfusion for
30 minutes. Tissues were dissected out and placed in
4CF1G to post-fix overnight at 4°C. Tissues were then
processed by UTHSCSA Electron Microscopy core. Core
processing steps as follows: (1) buffer rinse in 0.1 M
phosphate buffer for 5 minutes to overnight, (2) post-
fixation in 1% Zetterqvist’s buffered Osmium Tetroxide
for 30 minutes, (3) buffer rinse in Zetterqvist’s buffer for
3 minutes, (4) en bloc staining in 2% aqueous uranly
acetate for 20 minutes, (5) dehydration in 70% alcohol
for 10 minutes, then 95% alcohol for 10 minutes, then
100% alcohol twice for 10 minutes, then propylene oxide
twice for 10 minutes, (5) resin infiltration in 1:1 propyl-
ene oxide:resin for 30 minutes then 100% resin for 30 -
minutes under 25 psi vacuum. Once embedded, tissue
was sliced in 90 nm sections and placed on copper grids.
Grids were stained with uranyl acetate for 30 seconds
in the microwave and then with Reynold’s lead for
20 seconds. Samples were imaged at 80 kV on a JEOL
1230 electron microscope using AMT (advanced micros-
copy techniques) software.
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